Haven't used Aldexa Therapeutics yet?
Ask Trustburn

Ask Trustburn about Aldexa Therapeutics

Based on 12 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Andrew Pineda
Reviews 1

The company has done a great job with their products. I have been using them for a while now, and I am quite satisfied. The website is informative and easy to navigate. The only suggestion I have is to improve the customer support.

Jill Roe
Reviews 1

I would rate Aldexa Therapeutics as average. The website neuronsystemsinc.com looks professional and user-friendly. However, I feel that the information provided about their products could be more detailed. Overall, it's a decent company.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="neuronsystemsinc-com" data-lang="en"></div>
More widgets

About Aldexa Therapeutics

Aldexa Therapeutics, Inc. develops treatments for the dry form of age-related macular degeneration eye disease that may lead to blindness. It activities include the development of drugs to inhibit the formation of toxic metabolites that accumulate in the back of the eye. Aldexa Therapeutics, Inc. was formerly known as Neuron Systems, Inc. The company was incorporated in 2004 and is based in Burlington, Massachusetts. The company changed its name to Aldeyra Therapeutics, Inc. on March 17, 2014. Aldeyra held an initial public offering on May 7, 2014.